Circumvent the Tariff challenges with an agile supply chain Consulting
Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Sleeve Gastrectomy Devices Market
Market Size in USD Billion
CAGR :
%
USD
2.51 Billion
USD
3.97 Billion
2025
2033
Forecast Period
2026 –2033
Market Size(Base Year)
USD
2.51 Billion
Market Size (Forecast Year)
USD
3.97 Billion
CAGR
5.90
%
Major Markets Players
Medtronic (Ireland)
Johnson & Johnson Services Inc. (U.S.)
BD (U.S.)
Stryker (U.S.)
CONMED Corporation (U.S.)
Global Sleeve Gastrectomy Devices Market Segmentation, By Type (Tissue Closure Devices, Dissection and Positioning Devices), Application (Hospitals and Clinics, ASCs and Obesity Centers)- Industry Trends and Forecast to 2033
Sleeve Gastrectomy Devices Market Size
The global sleeve gastrectomy devices market size was valued at USD 2.51 billion in 2025 and is expected to reach USD 3.97 billion by 2033,at a CAGR of 5.90% during the forecast period
The market growth is largely fueled by the rising prevalence of obesity and related comorbidities, coupled with increasing awareness and acceptance of bariatric surgical procedures, leading to higher adoption across healthcare facilities worldwide
Furthermore, advancements in minimally invasive surgical technologies and growing demand for safe, efficient, and long-term weight management solutions are establishing sleeve gastrectomy devices as a preferred option in bariatric care. These converging factors are accelerating the adoption of these devices, thereby significantly boosting the industry's growth
Sleeve Gastrectomy Devices Market Analysis
Sleeve gastrectomy devices, used in bariatric procedures to reduce stomach size and support significant weight loss, are increasingly vital components of modern surgical weight management solutions in both hospitals and specialized clinics due to their effectiveness, minimally invasive nature, and long-term health benefits
The escalating demand for sleeve gastrectomy devices is primarily fueled by the rising global prevalence of obesity, increasing awareness about bariatric surgery, and a growing preference for minimally invasive procedures that ensure faster recovery and reduced surgical risks
North America dominated the sleeve gastrectomy devices market with the largest revenue share of 40.06% in 2025, characterized by advanced healthcare infrastructure, high adoption of bariatric procedures, and a strong presence of leading medical device manufacturers, with the U.S. experiencing substantial growth in surgical volumes driven by increasing obesity rates and favorable reimbursement policies
Asia-Pacific is expected to be the fastest growing region in the sleeve gastrectomy devices market during the forecast period due to expanding healthcare infrastructure, rising medical tourism, and increasing awareness regarding obesity treatment options
Tissue closure devices segment dominated the sleeve gastrectomy devices market with a market share of 43.7% in 2025, driven by their essential role in ensuring secure sealing, minimizing complications, and improving surgical outcomes in bariatric procedures
Growing demand for outpatient bariatric procedures
Increasing adoption of robotic-assisted and AI-integrated surgical systems
Value Added Data Infosets
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
Sleeve Gastrectomy Devices Market Trends
“Rising Adoption of Minimally Invasive and Precision-Based Bariatric Technologies”
A significant and accelerating trend in the global sleeve gastrectomy devices market is the growing adoption of minimally invasive surgical techniques and advanced laparoscopic technologies, enhancing procedural efficiency and patient safety across healthcare settings
For instance, advanced tissue closure and dissection devices are increasingly designed for laparoscopic sleeve gastrectomy, enabling surgeons to perform procedures with higher precision and reduced complication rates. Similarly, next-generation energy-based dissection tools are improving intraoperative control and surgical outcomes
Technological advancements in sleeve gastrectomy devices enable features such as improved sealing mechanisms, enhanced ergonomic designs, and integration with robotic-assisted platforms. For instance, some modern surgical systems utilize advanced stapling and closure technologies to minimize leakage risks and improve consistency in outcomes. Furthermore, these innovations support faster recovery times and reduced hospital stays, benefiting both patients and healthcare providers
The seamless integration of these devices with advanced surgical systems and digital operating room environments facilitates improved workflow and coordination during bariatric procedures. Through integrated platforms, surgeons can achieve better visualization, precision, and control, leading to optimized surgical performance and patient care
This trend towards more efficient, precise, and technologically advanced surgical solutions is fundamentally reshaping expectations in bariatric care. Consequently, companies are developing innovative sleeve gastrectomy devices with enhanced safety features, improved tissue handling, and compatibility with minimally invasive and robotic systems
The demand for advanced sleeve gastrectomy devices offering precision, safety, and minimally invasive capabilities is growing rapidly across hospitals and specialty obesity centers, as healthcare providers increasingly prioritize improved patient outcomes and operational efficiency
Growing integration of data-driven surgical planning and intraoperative monitoring tools is further enhancing procedural accuracy, enabling surgeons to make more informed decisions and improve overall surgical outcomes
Sleeve Gastrectomy Devices Market Dynamics
Driver
“Growing Need Due to Rising Obesity Prevalence and Bariatric Surgery Adoption”
The increasing prevalence of obesity and related chronic conditions, coupled with the growing acceptance of bariatric surgery, is a significant driver for the heightened demand for sleeve gastrectomy device
For instance, in April 2025, leading healthcare providers and device manufacturers focused on expanding bariatric surgery programs and enhancing surgical technologies to improve patient access and outcomes. Such strategies by key companies are expected to drive the sleeve gastrectomy devices market growth in the forecast period
As patients and healthcare professionals become more aware of the long-term health benefits of weight-loss surgeries, sleeve gastrectomy is emerging as a preferred option due to its effectiveness and relatively lower complication rates compared to other procedures
Furthermore, the growing availability of minimally invasive surgical options and advancements in hospital infrastructure are making these procedures more accessible, supporting increased adoption across both developed and emerging markets
The demand for efficient surgical tools, improved patient safety, and shorter recovery times is propelling the adoption of advanced sleeve gastrectomy devices in hospitals, clinics, and specialized obesity centers. The trend towards early intervention and increasing insurance coverage for bariatric procedures further contributes to market growth
Rising government and healthcare initiatives promoting obesity management and preventive care are further supporting the adoption of bariatric procedures, thereby boosting demand for related surgical devices
Expanding medical tourism in emerging economies is attracting international patients seeking cost-effective bariatric surgeries, increasing procedural volumes and driving device utilization
Restraint/Challenge
“High Procedure Costs and Surgical Risks Limiting Adoption”
Concerns surrounding the high cost of bariatric procedures and associated surgical risks pose a significant challenge to broader market penetration. As sleeve gastrectomy involves specialized devices and skilled professionals, it can be financially burdensome for many patients, limiting accessibility
For instance, reports of post-surgical complications such as leakage, infection, or nutritional deficiencies have made some patients hesitant to undergo bariatric surgery, including sleeve gastrectomy procedures
Addressing these concerns through improved device safety, enhanced surgical training, and better post-operative care is crucial for increasing patient confidence. Companies are focusing on developing safer tissue closure and dissection devices to minimize complications and improve outcomes. In addition, limited reimbursement policies in certain regions can further restrict access to these procedures, particularly in low- and middle-income countries
While technological advancements are improving safety and efficiency, the overall cost of surgery and devices remains relatively high, creating barriers for widespread adoption among cost-sensitive populations
Overcoming these challenges through cost optimization, expanded insurance coverage, and continuous innovation in safer and more efficient devices will be vital for sustained market growth
Shortage of skilled bariatric surgeons and trained professionals in certain regions can limit the number of procedures performed, thereby restricting market expansion
Stringent regulatory requirements and approval processes for surgical devices can delay product launches and increase compliance costs for manufacturers
Sleeve Gastrectomy Devices Market Scope
The market is segmented on the basis of type and application
By Type
On the basis of type, the sleeve gastrectomy devices market is segmented into tissue closure devices and dissection and positioning devices. The tissue closure devices segment dominated the market with the largest market revenue share of 43.7% in 2025, driven by their critical role in ensuring secure sealing of gastric tissues during sleeve gastrectomy procedures. These devices are essential for minimizing the risk of post-operative complications such as leakage and bleeding, making them indispensable in bariatric surgeries. Surgeons heavily rely on advanced closure technologies to enhance procedural safety and improve patient outcomes. In addition, continuous advancements in stapling and suturing technologies, along with improved ergonomic designs, are further strengthening the dominance of this segment. The growing volume of bariatric procedures globally is also contributing to sustained demand for tissue closure devices across hospitals and specialized centers.
The dissection and positioning devices segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by increasing adoption of minimally invasive surgical techniques and the need for enhanced precision during procedures. These devices assist surgeons in accurate tissue separation and optimal positioning, which are crucial for successful surgical outcomes. With the rising integration of laparoscopic and robotic-assisted surgeries, demand for advanced dissection tools is increasing significantly. Furthermore, technological innovations such as energy-based devices and improved visualization systems are boosting their effectiveness and adoption. The expansion of bariatric surgery centers and increasing surgeon preference for precision-driven tools are also supporting the rapid growth of this segment.
By Application
On the basis of application, the sleeve gastrectomy devices market is segmented into hospitals and clinics and ASCs and obesity centers. The hospitals and clinics segment dominated the market with the largest market revenue share in 2025, driven by the high volume of bariatric surgeries performed in these settings due to the availability of advanced surgical infrastructure and skilled healthcare professionals. Hospitals are typically equipped with comprehensive facilities required for complex procedures, including intensive care units and post-operative monitoring systems. The presence of experienced bariatric surgeons and multidisciplinary care teams further enhances patient outcomes, making hospitals the preferred choice for such surgeries. In addition, favorable reimbursement policies and higher patient inflow contribute to the strong position of this segment. Continuous investments in healthcare infrastructure and adoption of advanced surgical technologies are also reinforcing the dominance of hospitals and clinics.
The ASCs and obesity centers segment is anticipated to witness the fastest growth rate from 2026 to 2033, driven by the increasing preference for cost-effective and minimally invasive procedures in outpatient settings. These centers offer shorter hospital stays, reduced overall treatment costs, and faster recovery times, making them attractive to both patients and healthcare providers. Advancements in surgical techniques and anesthesia have enabled more bariatric procedures to be safely conducted in ambulatory settings. Furthermore, the rising establishment of specialized obesity treatment centers focusing on bariatric care is boosting segment growth. The growing trend towards same-day discharge and increasing patient awareness regarding outpatient surgical options are also accelerating the adoption of sleeve gastrectomy devices in this segment.
North America dominated the sleeve gastrectomy devices market with the largest revenue share of 40.06% in 2025, characterized by advanced healthcare infrastructure, high adoption of bariatric procedures, and a strong presence of leading medical device manufacturers
Patients in the region highly value the effectiveness, safety, and long-term health benefits offered by sleeve gastrectomy procedures, supported by advanced surgical technologies and skilled healthcare professionals
This widespread adoption is further supported by well-established healthcare infrastructure, favorable reimbursement policies, and a strong presence of leading medical device manufacturers, establishing sleeve gastrectomy devices as a preferred solution across hospitals and specialized obesity treatment centers
U.S. Sleeve Gastrectomy Devices Market Insight
The U.S. sleeve gastrectomy devices market captured the largest revenue share of 81% in 2025 within North America, fueled by the rising prevalence of obesity and the increasing adoption of bariatric surgical procedures. Patients are increasingly prioritizing effective and long-term weight management solutions through minimally invasive surgeries. The growing preference for advanced laparoscopic procedures, combined with strong demand for improved surgical outcomes and faster recovery times, further propels the market. Moreover, the increasing integration of advanced surgical technologies and robotic-assisted systems is significantly contributing to the market's expansion.
Europe Sleeve Gastrectomy Devices Market Insight
The Europe sleeve gastrectomy devices market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing obesity rates and the rising demand for effective weight-loss interventions. The increase in healthcare awareness, coupled with the adoption of advanced surgical techniques, is fostering the growth of bariatric procedures. European patients are also drawn to the long-term health benefits and improved quality of life offered by these surgeries. The region is experiencing significant growth across hospitals and specialized obesity centers, with sleeve gastrectomy procedures being incorporated into both public and private healthcare systems.
U.K. Sleeve Gastrectomy Devices Market Insight
The U.K. sleeve gastrectomy devices market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by the increasing prevalence of obesity and a rising focus on preventive healthcare. In addition, growing awareness regarding bariatric surgery and its effectiveness is encouraging both patients and healthcare providers to adopt these procedures. The UK’s advanced healthcare system, alongside its expanding access to specialized bariatric care services, is expected to continue to stimulate market growth.
Germany Sleeve Gastrectomy Devices Market Insight
The Germany sleeve gastrectomy devices market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing demand for minimally invasive surgical procedures and advanced healthcare solutions. Germany’s well-developed medical infrastructure, combined with its emphasis on innovation and precision in surgical care, promotes the adoption of sleeve gastrectomy devices. The integration of advanced surgical technologies is also becoming increasingly prevalent, with a strong preference for safe and efficient treatment solutions aligning with patient expectations.
The Asia-Pacific sleeve gastrectomy devices market is poised to grow at the fastest CAGR of 24% during the forecast period of 2026 to 2033, driven by increasing obesity prevalence, rising disposable incomes, and improving healthcare infrastructure in countries such as China, Japan, and India. The region's growing awareness regarding bariatric surgery, supported by government healthcare initiatives, is driving the adoption of sleeve gastrectomy procedures. Furthermore, as APAC emerges as a key hub for medical tourism, the accessibility and affordability of bariatric surgeries are expanding to a wider patient population.
Japan Sleeve Gastrectomy Devices Market Insight
The Japan sleeve gastrectomy devices market is gaining momentum due to the country’s advanced healthcare system, increasing obesity concerns, and demand for effective treatment options. The Japanese market places a significant emphasis on safety and precision, and the adoption of sleeve gastrectomy devices is driven by the growing number of minimally invasive procedures. The integration of advanced surgical technologies with bariatric care is fueling growth. Moreover, Japan's aging population is likely to spur demand for safer and efficient surgical solutions in both hospitals and specialized clinics.
India Sleeve Gastrectomy Devices Market Insight
The India sleeve gastrectomy devices market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country's growing obesity burden, rapid urbanization, and increasing healthcare awareness. India stands as one of the fastest-growing markets for bariatric procedures, and sleeve gastrectomy is becoming increasingly popular in hospitals and specialized obesity centers. The push towards improved healthcare infrastructure and the availability of cost-effective surgical options, alongside rising medical tourism, are key factors propelling the market in India.
Sleeve Gastrectomy Devices Market Share
The Sleeve Gastrectomy Devices industry is primarily led by well-established companies, including:
Medtronic (Ireland)
Johnson & Johnson Services, Inc. (U.S.)
BD (U.S.)
Stryker (U.S.)
CONMED Corporation (U.S.)
Olympus Corporation (Japan)
Intuitive Surgical, Inc. (U.S.)
B. Braun SE (Germany)
Karl Storz SE & Co. KG (Germany)
Smith & Nephew plc (U.K.)
Teleflex Incorporated (U.S.)
Cook Medical (U.S.)
Applied Medical Resources Corporation (U.S.)
Purple Surgical (U.K.)
Grena Ltd. (U.K.)
Reach Surgical, Inc. (China)
Victor Medical Instruments Co., Ltd. (China)
OptoMedic Technologies, Inc. (China)
LaproSurge Ltd. (India)
Meril Life Sciences Pvt. Ltd. (India)
What are the Recent Developments in Global Sleeve Gastrectomy Devices Market?
In January 2026, GT Metabolic received approval in Canada for a novel magnetic surgical technology used in bariatric procedures, enabling less invasive techniques for joining intestinal segments. This breakthrough approach represents a shift toward alternative device-based solutions that could complement or enhance traditional sleeve gastrectomy procedures by reducing invasiveness and improving recovery outcomes
In November 2025, Medtronic plc announced the launch of advanced bariatric surgical instruments designed to enhance precision, procedural efficiency, and patient recovery outcomes. These next-generation devices focus on improving laparoscopic performance and minimizing complications during procedures such as sleeve gastrectomy. The innovation highlights the company’s continued investment in advanced surgical technologies aimed at improving bariatric care globally
In June 2025, Johnson & Johnson MedTech announced the U.S. launch of the ETHICON™ 4000 Stapler, an advanced surgical stapling system designed to improve staple line integrity and reduce risks of leaks and bleeding during procedures such as sleeve gastrectomy. The device incorporates 3D stapling technology and enhanced gripping features to manage complex tissue conditions, highlighting ongoing innovation in tissue closure devices
In May 2025, Bumrungrad International Hospital introduced a combined treatment approach integrating endoscopic sleeve gastroplasty (ESG) with GLP-1 therapies such as semaglutide and tirzepatide. This development represents a shift toward less invasive, hybrid treatment solutions that complement traditional sleeve gastrectomy procedures. The approach demonstrated significant weight loss outcomes and reflects innovation in device-assisted bariatric techniques
In March 2025, advancements in robotic-assisted bariatric surgery, including systems such as the da Vinci Surgical System, were highlighted as transformative in improving precision and safety in sleeve gastrectomy procedures. These systems provide enhanced 3D visualization and dexterity, enabling more accurate staple placement and reducing complication risks. This development underscores the growing integration of robotics with bariatric surgical devices
SKU-69127
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future